TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr |
What is the latest Profit After Tax of TORRENT PHARMACEUTICALS ?
Year | Profit After Tax |
---|---|
Mar2025 | ₹1,656 Cr |
Mar2024 | ₹1,245 Cr |
Mar2023 | ₹777 Cr |
Mar2022 | ₹1,252 Cr |
Mar2021 | ₹1,025 Cr |
How is Profit After Tax of TORRENT PHARMACEUTICALS Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹1,656 Cr | 33.02 | |
Mar2024 | ₹1,245 Cr | 60.22 | |
Mar2023 | ₹777 Cr | -37.92 | |
Mar2022 | ₹1,252 Cr | 22.17 | |
Mar2021 | ₹1,025 Cr | - |
Compare Profit After Tax of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹120,683.6 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,126.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics | |
MANKIND PHARMA | ₹106,486.0 Cr | 0.1% | 6.1% | 6.2% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -1.2% |
-1.7% |
4.5% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses